Cargando…
Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
[Image: see text] Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), are characterized by deposits of amyloid proteins. The homeostasis of metal ions is crucial for the normal biological functions in the brain. However, in AD and PD, the imbalance of metal ion...
Autores principales: | Ben-Shushan, Shira, Miller, Yifat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389909/ https://www.ncbi.nlm.nih.gov/pubmed/33570949 http://dx.doi.org/10.1021/acs.jpcb.0c11151 |
Ejemplares similares
-
Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
por: Li, Chunrong, et al.
Publicado: (2019) -
Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases
por: Carniglia, Lila, et al.
Publicado: (2017) -
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019) -
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative
Disease
por: Pain, Stéphanie, et al.
Publicado: (2022) -
EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
por: Fulgenzi, Alessandro, et al.
Publicado: (2020)